Indoline derivatives for treatment and/or prevention of fibrosis diseases
US11278523B2 · kind B2 · utility
1Cited by
2References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 27, 2015 |
| Grant date | Mar 22, 2022 |
| Priority date | — |
| Expiry date | Oct 27, 2035 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2300/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to the use of Indoline derivatives, and their effective dose in the prevention and/or treatment of fibrosis diseases. The compound can effectively prevent and/or treat a fibrosis disease without cytotoxicity or genotoxicity.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.